/PRNewswire/ EXoPERT Corporation, a leading developer leveraging Raman Spectroscopy and Artificial Intelligence (AI) for Multi Cancer Early Detection, today.
Nouscom s Off-the-Shelf Cancer Vaccine, NOUS-209, Shows Potential to Intercept Cancer in Subjects with Lynch Syndrome pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
The University of Texas MD Anderson Cancer Center and Panacea Venture today announced the launch of Manaolana Oncology Inc., a new company created to develop and advance antibody-based therapies against novel cancer antigens.